cholesterol from various intracellular organelles. In this respect, specialized nonvesicular lipid transporters of the superfamily of proteins with a steroidogenic acute regulatory (StAR)-related lipid transfer (START) domain were shown to be involved in lipids and cholesterol traffi cking between intracellular membranes ( 4-7 ).The START superfamily is defi ned by the presence of a conserved amino acid sequence of typically 210 amino acids that folds into an ␣ /  helix-grip structure forming a hydrophobic pocket for ligand binding ( 5,(8)(9)(10)(11)(12)(13)(14)(15)(16) ). This module is conserved throughout the evolution and is involved in the transport of ligands, namely lipids, in mammals.Fifteen mammalian proteins, divided into six subfamilies possess a START domain ( 4,5,11,17,18 ), and two of these subfamilies, STARD1 and STARD4, are reported to bind sterols. The STARD1 subfamily is composed of STARD1 and STARD3. STARD1 (StAR) is the archetype of START domain-containing protein; it binds cholesterol, possesses a mitochondrial leader peptide, and is involved in the transfer of cholesterol into mitochondria in steroidogenic tissues ( 11,(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30) and in hepatocytes ( 31-33 ).The second STARD1 subfamily member, STARD3 (metastatic lymph node 64, MLN64), also binds cholesterol ( 16 ). STARD3 is a membrane protein that is targeted to the late endosomes by an N-terminal region domain ( 34 ). The subcellular localization of STARD1 and STARD3 suggests different roles in cellular cholesterol traffi cking between these two proteins. It was also suggested that STARD3 might serve to maintain cholesterol at the membrane of late endosomes prior to its shuttle to cytoplasmic acceptor(s) through the START domain ( 34 ).
Abstract Steroidogenic acute regulatory-related lipid transfer (START) domain proteins are involved in the nonvesicu